Role of Dok-1 and Dok-2 in Leukemia Suppression

Chronic myelogenous leukemia (CML) is characterized by the presence of the chimeric p210(bcr/abl) oncoprotein that shows elevated and constitutive protein tyrosine kinase activity relative to the normal c-abl tyrosine kinase. Although several p210(bcr/abl) substrates have been identified, their rele...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Niki, Masaru, Di Cristofano, Antonio, Zhao, Mingming, Honda, Hiroaki, Hirai, Hisamaru, Van Aelst, Linda, Cordon-Cardo, Carlos, Pandolfi, Pier Paolo
Format: Artigo
Idioma:Inglês
Publicat: The Rockefeller University Press 2004
Matèries:
Brief Definitive Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2211998/
https://ncbi.nlm.nih.gov/pubmed/15611295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20041306
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars